跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
PPB
/
CLARITYNE-D EXTENDED-RELEASE TABLETS
Approved
STANDARD
CLARITYNE-D EXTENDED-RELEASE TABLETS
BAYER HEALTHCARE LIMITED
🇰🇪 Pharmacy and Poisons Board
Approval Date
Apr 1, 2026
Approval ID
88dbac28e3b04f82
Company
BAYER HEALTHCARE LIMITED
Type
Standard
Approval Details
Approval Id
88dbac28e3b04f82
Product Name
CLARITYNE-D EXTENDED-RELEASE TABLETS
Drug Hk Name
CLARITYNE-D EXTENDED-RELEASE TABLETS
Registration Code
HK-69033
Company Name
BAYER HEALTHCARE LIMITED
Company Detail Path
/organization/bayer-healthcare-limited
Registration Category
Part 1 Poison
Sale Requirement
Pharmacy only Medicines
Registration Date
2026-03-23
Company Address
14/F, OXFORD HOUSE, TAIKOO PLACE, 979 KING’S ROAD, QUARRY BAY, HONG KONG
Active Ingredients
Approved
Quick Info
Agency
PPB
Country
🇰🇪
Approval Date
Apr 1, 2026
Approval ID
88dbac28e3b04f82
Type
Standard
Back to PPB Approvals
CLARITYNE-D EXTENDED-RELEASE TABLETS - PPB Drug Approval Details